SU-Holdings Co.,Ltd. (031860.KQ)
- Previous Close
160.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
1,600.00 - 1,600.00 - 52 Week Range
1,500.00 - 13,030.00 - Volume
0 - Avg. Volume
769,526 - Market Cap (intraday)
19.006B - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd. and changed its name to SU-Holdings Co.,Ltd. in July 2023. SU-Holdings Co.,Ltd. was founded in 1979 and is based in Seoul, South Korea.
su-holdings.com--
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: 031860.KQ
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 031860.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 031860.KQ
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-280.59%
Return on Assets (ttm)
-13.83%
Return on Equity (ttm)
-54.35%
Revenue (ttm)
11.31B
Net Income Avi to Common (ttm)
-31.73B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
11.56B
Total Debt/Equity (mrq)
5.37%
Levered Free Cash Flow (ttm)
-7.85B